BE & Pathology Joint Seminar: “Extracellular vesicles and microglia as biomarker and therapeutic intervention of Alzheimer’s disease and related disorders” (Tsuneya Ikezu, Mayo Clinic)

Dr. Ikezu is Senior Associate Consultant at Department of Neuroscience, Mayo Clinic Florida and Adjunct Professor at Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine. He had extensive pre- and post-doctoral trainings in the premier medical institutes in Japan and US specialized in immunology (UCSF and UNMC), pharmacology (Harvard), and neuroscience (Cleveland Clinic and UNMC). He has been investigating the pathophysiology of neurodegenerative disorders, such as Alzheimer’s disease (AD), frontotemporal dementia (FTD), and HIV-associated dementia using various transgenic and gene-targeted mouse models. He is especially interested in the molecular mechanism of Alzheimer’s disease pathogenesis. He has been consistently publishing his research in the first-rated journals, such as Sci Transl Med, Nat Neurosci, J. Extracell Vesicles, Alz Dement, EMBO J, PNAS, Brain, and Acta Neuropathol and has been obtaining extramural funding from various sources including NIH. He has also edited a major textbook (Neuroimmune Pharmacology, Springer 2008 and 2017) as a senior editor, which is internationally used for graduate education of neuroimmunology and neuropharmacology.